Perspectives on osteoporosis in pediatric inflammatory bowel disease

Related Experiment Videos

Manisha Harpavat1, David J Keljo

  • 1University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213-2583, USA. Manisha.Harpavat@chp.edu

Insights

Pediatric osteoporosis is a growing concern in chronic illnesses like inflammatory bowel disease (IBD). Children with IBD face decreased bone density and higher fracture risks, necessitating further research and established guidelines.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Bone Metabolism

Background:

  • Osteoporosis is increasingly identified as a significant health issue in children with chronic illnesses.
  • Children diagnosed with inflammatory bowel disease (IBD) exhibit reduced bone mineral density and an elevated risk of fractures.
  • Recent research has enhanced the understanding of the mechanisms driving bone loss in this population.

Purpose of the Study:

  • To review the current knowledge on osteopenia and osteoporosis in pediatric patients with IBD.
  • To highlight the various risk factors contributing to bone loss in these children.
  • To discuss diagnostic methods and the need for established clinical guidelines.

Main Methods:

  • Literature review of recent studies on pediatric osteoporosis and IBD.
  • Analysis of established and emerging diagnostic techniques for bone mineral density assessment.
  • Synthesis of current understanding regarding the pathogenesis of bone loss.

Main Results:

  • Children with IBD are at significant risk for decreased bone mineral density and fractures.
  • Multiple risk factors contribute to the development of osteopenia and osteoporosis in pediatric IBD.
  • Dual-energy x-ray absorptiometry is the current standard for bone density assessment, with ongoing exploration of alternative methods.

Conclusions:

  • Osteoporosis is a recognized complication in children with chronic conditions, particularly IBD.
  • Further research is needed to elucidate the pathogenesis and identify all contributing risk factors.
  • The absence of established diagnostic and treatment guidelines for pediatric osteoporosis underscores the need for clinical consensus and development.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...